Comparative Pharmacology
Head-to-head clinical analysis: M V I PEDIATRIC versus M V I 12 LYOPHILIZED.
Peer-Reviewed Evidence
Head-to-head clinical analysis: M V I PEDIATRIC versus M V I 12 LYOPHILIZED.
M.V.I. PEDIATRIC vs M.V.I.-12 LYOPHILIZED
Head-to-head clinical comparison of therapeutic indices and safety profiles.
Multivitamin preparation providing essential vitamins (A, C, D, E, K, B1, B2, B3, B5, B6, B7, B9, B12) as cofactors for enzymatic reactions, antioxidant functions, and maintenance of normal metabolic processes.
Provides essential vitamins for normal metabolic function, acting as cofactors in enzymatic reactions, including energy production, red blood cell synthesis, and antioxidant defense.
FDA-approved: prevention and treatment of vitamin deficiencies in pediatric patients requiring parenteral nutrition.
FDA-approved for the prevention and treatment of vitamin deficiencies in patients requiring parenteral nutrition.
Intravenous infusion: 5 mL (1 vial) added to appropriate IV fluid, administered over 30 minutes daily.
10 mL (one vial) intravenously once daily, infused over at least 30 minutes.
None Documented
None Documented
Variable; vitamin A: 9-25 days (stored in liver), vitamin D: 2-3 weeks (fat-soluble), vitamin C: 10-20 hours (renal function dependent), B-complex: 1-10 hours. Clinical context: accumulation risk in renal impairment.
Variable by vitamin: thiamine ~24h, riboflavin ~18h, pyridoxine ~30h, cyanocobalamin ~6 days, ascorbic acid ~8h, retinol ~20h, ergocalciferol ~19 days, alpha-tocopherol ~10h, phytonadione ~4h. Clinical context: short t1/2 of water-soluble vitamins requires daily dosing; long t1/2 of fat-soluble vitamins allows less frequent dosing but risk of accumulation.
Vitamins are metabolized via various pathways: water-soluble vitamins (B complex, C) are primarily metabolized in the liver and excreted renally; fat-soluble vitamins (A, D, E, K) are stored in adipose tissue and liver, metabolized via hepatic enzymes, and excreted in bile/feces.
Vitamins are metabolized via various pathways in the liver and tissues, including phosphorylation, dephosphorylation, and oxidation-reduction reactions.
Renal: 60-80% (free vitamins), Biliary/fecal: 10-20% (unabsorbed and metabolites).
Renal: water-soluble vitamins (B-complex, C) are excreted primarily via kidneys, with excess eliminated unchanged. Fat-soluble vitamins (A, D, E, K) are eliminated via bile and feces; renal excretion is minimal. Specific percentages: thiamine 80-90% renal, riboflavin 60-70% renal, pyridoxine 70-80% renal, cyanocobalamin 50-60% renal, ascorbic acid 60-70% renal; fat-soluble vitamins >90% biliary/fecal.
Vitamin A: 90% (retinol-binding protein); Vitamin D: 85-90% (vitamin D-binding protein); Vitamin E: 90% (lipoproteins); Vitamin K: 99% (lipoproteins); B12: 90% (transcobalamins); other B vitamins: minimal to moderate (10-30%).
Variable: thiamine ~10% bound to albumin; riboflavin ~30% bound to albumin; pyridoxine ~60% bound to albumin; cyanocobalamin bound to transcobalamins (~20%); ascorbic acid ~5% bound; retinol bound to retinol-binding protein (RBP) ~100%; ergocalciferol bound to vitamin D-binding protein (DBP) ~90%; alpha-tocopherol bound to lipoproteins ~90%; phytonadione bound to lipoproteins ~95%.
0.5-1.0 L/kg for water-soluble; 1.5-3.0 L/kg for fat-soluble (due to tissue storage). Clinical meaning: extensive tissue distribution, especially liver for fat-soluble vitamins.
Extensive for fat-soluble vitamins: retinol ~5 L/kg, ergocalciferol ~10 L/kg, alpha-tocopherol ~10 L/kg; water-soluble vitamins have Vd approximating total body water: thiamine ~0.6 L/kg, riboflavin ~0.5 L/kg, ascorbic acid ~0.4 L/kg. Clinical meaning: large Vd indicates extensive tissue distribution and storage.
IV: 100% (only route); other routes not recommended (IM or SC may cause tissue damage or unpredictable absorption with fat-soluble vitamins).
Intravenous: 100%. No oral formulation; M.V.I.-12 is for IV use only.
No specific dose adjustment required; however, caution in severe renal impairment due to potential accumulation of vitamins.
No specific dose adjustment required for renal impairment.
No specific dose adjustment required; monitor for vitamin A toxicity in Child-Pugh Class B/C.
No specific dose adjustment required for hepatic impairment.
Children 11 years and younger: 5 mL (1 vial) intravenously daily. For infants <1 year, use M.V.I. Pediatric only per manufacturer guidelines.
For children weighing <40 kg: 0.25 mL/kg/day (max 10 mL) intravenously once daily. For children weighing ≥40 kg: same as adult dose (10 mL once daily).
No specific dose adjustment; monitor renal function and vitamin levels with prolonged use.
Standard adult dosing; no specific geriatric adjustment required.
Not applicable.
None.
["Contains vitamin K; caution in patients on anticoagulants (may antagonize warfarin).","Contains aluminum; may accumulate with prolonged use in renal impairment.","Risk of allergic reactions including anaphylaxis (especially with vitamin B1/thiamine).","Monitor liver function due to potential hepatotoxicity with high doses of vitamin A.","Do not exceed recommended doses to avoid toxicity (especially fat-soluble vitamins)."]
["Hypersensitivity reactions may occur, especially in patients with allergies to thiamine or other components.","Monitor for signs of vitamin toxicity, particularly vitamins A and D.","Use with caution in patients with renal impairment due to potential accumulation of fat-soluble vitamins.","Administer only as an additive to intravenous fluids; do not give as a direct infusion."]
["Hypersensitivity to any component.","Pre-existing hypervitaminosis (e.g., vitamin A, D).","Severe renal impairment with inability to excrete aluminum."]
["Hypersensitivity to any component of the formulation.","Patients with preexisting hypervitaminosis."]
Data Pending Review
Data Pending Review
No specific food interactions due to intravenous administration. However, patients receiving TPN should follow dietary restrictions as advised by their healthcare team to avoid metabolic imbalances.
No direct food interactions known as the drug is administered intravenously. However, patients on parenteral nutrition may have dietary restrictions based on underlying condition (e.g., renal, hepatic). Vitamin K content may affect warfarin therapy; monitor INR if applicable.
M.V.I. PEDIATRIC contains vitamins and minerals at recommended daily allowances. Vitamin A (retinol) at doses below 10,000 IU/day is not associated with increased teratogenic risk; however, high doses (>10,000 IU/day) are teratogenic. The product's vitamin A content (2300 IU per 5 mL) is below the teratogenic threshold. No known teratogenic effects from other components at physiological doses. For all trimesters, use is considered safe when administered according to recommended doses.
M.V.I.-12 Lyophilized contains vitamins A, D, E, K, C, B1, B2, B3, B5, B6, B9, B12. Vitamin A at high doses (>10,000 IU/day) is teratogenic in first trimester. Vitamin D excessive doses may cause fetal hypercalcemia. Vitamin K at high doses may increase neonatal jaundice risk. Folic acid supplementation is beneficial for neural tube defect prevention. Individual vitamin components should be reviewed; the combination product at recommended doses is generally considered low risk but requires monitoring of vitamin A and D levels.
Compatible with breastfeeding. Vitamins and minerals in M.V.I. PEDIATRIC are natural constituents of human milk. M/P ratios not established for the multi-vitamin mixture; individual vitamins transfer minimally. No adverse effects reported in nursed infants.
Most components are excreted into breast milk, but the product at recommended doses is compatible with breastfeeding. The milk-to-plasma ratio varies by component; for example, vitamin A M/P ratio is approximately 0.5-0.7, vitamin D is low. High doses of vitamin A or D may accumulate in infant and should be avoided. Caution with vitamin K if infant has deficiency or bleeding risk.
No dose adjustment required. Pregnancy may increase requirements for certain vitamins (e.g., folic acid, iron), but M.V.I. PEDIATRIC is dosed per pediatric recommendations; for pregnant women, use should follow prenatal vitamin dosing guidelines. No pharmacokinetic changes necessitate dose adjustments for this product.
No specific dose adjustments required for pregnancy; use standard dosing. Ensure that vitamin A does not exceed 10,000 IU/day to avoid teratogenicity. Monitor for increased needs of folic acid (400-800 mcg/day) and iron (if part of separate regimen). Pharmacokinetic changes in pregnancy (e.g., increased plasma volume) do not necessitate dose changes for this multivitamin product.
Category C
Category C
M.V.I. PEDIATRIC is a multivitamin formulation for intravenous use in children. Ensure compatibility with TPN solutions; protect from light to prevent degradation. Monitor for allergic reactions, especially in patients with sensitivities to vitamins. Do not exceed recommended infusion rates to avoid adverse effects. Contains vitamin K; caution in patients on warfarin therapy.
M.V.I.-12 Lyophilized is a multivitamin formulation for intravenous infusion in patients requiring parenteral nutrition. It contains 12 vitamins (including fat-soluble A, D, E, K and water-soluble B complex, C). Monitor for allergic reactions, especially in patients with thiamine (B1) sensitivity. Add to IV fluids just before administration; protect from light to prevent degradation. Do not exceed recommended dose; avoid rapid infusion. Caution in patients with renal impairment or electrolyte imbalances due to additives.
This medication provides essential vitamins when you cannot eat or drink enough.It is given intravenously, typically as part of total parenteral nutrition.Notify the healthcare provider if you experience any signs of allergic reaction such as rash, itching, or trouble breathing.Your doctor will monitor your vitamin levels and overall health during treatment.Inform your doctor about any other medications you are taking, especially blood thinners.
This medication is used to provide essential vitamins when you cannot eat or drink normally.It is given through a vein (IV) and must be infused slowly.Report any signs of allergic reaction such as rash, itching, swelling, or trouble breathing immediately.Tell your doctor if you have kidney problems or any food allergies.Do not use this product if it is discolored or contains particles.